RecruitingNCT07384221
Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients
Studying Pemphigus vulgaris
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Saglik Bilimleri Universitesi
- Principal Investigator
- Nuriye Işıl Saygun, ProfessorUniversity of Health Sciences, Gulhane Faculty of Dentistry, Department of Periodontology
- Intervention
- Clinical Periodontal and Oral Evaluation(other)
- Enrollment
- 20 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2026
Study locations (1)
- University of Health Sciences, Gulhane Faculty of Dentistry, Department of Periodontology, Ankara, Turkey (Türkiye)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07384221 on ClinicalTrials.govOther trials for Pemphigus vulgaris
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT04422912A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)Cabaletta Bio
- RECRUITINGNCT02753777Autoimmune Blistering Diseases StudyUniversity of Pennsylvania